The mechanisms of the renal excretion of AM-715, a synthetic antimicrobial agent, were studied in rabbits, dogs, and humans. In both rabbits and humans, clearance was greater than creatinine clearance and was profoundly decreased by the administration of probenecid. Thus, in these subjects, AM 715 was cleared by both tubular secretion and glomerular filtration. In dogs, however, the excretion ratio (close to unity), biological half-life, and stop-flow pattern of AM-715 were not affected by probenecid, indicating that the renal excretion of AM-715 took place mostly through glomerular filtration. These results suggest that renal excretion of AM-715 differs with animal species.
new synthetic antibacterial agent with a broad spectrum of activity covering both gram-positive and gram-negative organisms (6, 9) . In humans, AM-715 is eliminated predominantly by renal excretion and is metabolized only to a small extent (13) . Little is known, however, of the mechanisms by which AM-715 is excreted and, specifically, whether it is actively secreted by the renal tubules in a fashion similar to that of such organic acids as nalidixic acid (7) , piromidic acid (7), pipemidic acid (10) , miloxacin (7) , or cinoxacin (8, 14) . The purpose of the present study was to examine the mechanism of renal excretion of AM-715 in rabbits, dogs, and humans. To facilitate this evaluation, AM- MATERIALS AND METHODS Renal clearance in rabbits. Five male Japanese White rabbits, weighing 2.8 to 3.4 kg, were used. They were anesthetized with 30 mg of pentobarbital sodium per kg of body weight, administered in the vein of the foreleg. Urine was collected through a cannula inserted in the left ureter. The left femoral artery and auricular vein were catheterized with polyethylene tubes for sampling of blood and administration of drug solution, respectively. A polyethylene catheter was placed in the aorta through the right femoral artery, and blood pressure was monitored by a pressure transducer (type MP4T; Nihon Koden, Ltd.). The urinary bladder was cannulated for the drainage of accumulating urine. After completion of these surgical preparations by methods described previously (5) , an intravenous infusion of 10%o mannitol (JP IX; Towa Kasei Kogyo Co., Ltd.) in isotonic saline (solution I) was started at the rate of 1.0 mllmin. When urine flow had stabilized, urine was collected during a 5-min interval, and blood was taken at the midpoint of the interval. Each sample was used as a blank for determining the concentration of inulin, which was injected intravenously through the auricular vein at a priming dose of 40 mg/kg and sustained by the infusion of 0.12% inulin solution in solution I (solution II) at the rate of 1.0 ml/min. After 60 min of the infusion, urine and blood were collected as a blank for the determination of AM-715 concentration. Then, AM-715 was infused at the rate of 0.13 mg/kg per min. The infusion solution was prepared by mixing a 5% aqueous solution of AM-715 (pH 5.0) with solution II. Urine samples were collected during three successive 5-min intervals, beginning 30 min after the start of infusion. Blood samples were taken at the midpoint of urine collections. After these procedures were completed, a single dose of 30 mg of probenecid (GR; Sigma Chemical Co.) per kg was administered intravenously, and urine and blood samples were collected again in a manner similar to that described above.
Renal clearance in dogs. Three male beagles weighing 11.0 to 14.5 kg each were used in this study. The experimental design and procedure were the same as those used in renal clearance experiments in rabbits, except solutions were infused more rapidly (3 mlmin), and three consecutive administrations of solution II containing AM-715 were used at the rates of 0.06, 0.09, and 0.12 mg of AM-715 per kg per min. Beginning 30 min after the infusion of AM-715, urine was collected 2AANTIMICROB. AGENTS CHEMOTHER. The concentrations of AM-715 in rabbit and dog urine and serum were assayed by high-pressure liquid chromatography as follows. To 1 ml od'plasma and diluted urine samples, 2 ml of water.,sad 1 ml of 15% tric*orowetic acid (GR; E. Merck AG) wore added.
The.mixture was shaken well with a mechanical strrer and centrifuged for 10 min at 3,000rpm at room temperature. To 3 ml of the supeaant, 0.5 oq of 2 N NaOH and 0.5 ml of acetic anhydride (special gade; Nippon Rikagakuyakuhin Co.) were added. The mixture was allowed to stand in boiling water for S min.
After cooling, 1 ml of 2 N HCI was added to the 2 SHIMADA ET AL. mixture. AM-715 was extracted from the cooled acidic mixture to 5 ml of dichloromethane (special grade; Nippon Rikagakuyakuhin Co.), and 4 ml of the dichloromethane layer was removed, washed twice with 3 ml of distilled water, and evaporated to dryness. The residue was dissolved with 0.5 ml of a 5:5:1 (vol/vol) mixture of chloroform-methanol-28% ammonia water containing the amine form of AM-715, 7-amino-1-ethyl-6-fluoro-1 ,4-dihydro-4-oxo-3-quinolinecarboxylic acid, as an internal standard (ca. 2 ,ug/ml). Samples were chromatographed on a Hitachi model 635A liquid chromatograph at 35°C, using a 150-mm stainless steel column (2.6-mm inner diameter) packed with LiChrosorb Si 100 (5 pm; E. Merck AG). The eluting mobile phase was a 100:150:20:14 (vol/vol) mixture of dichloromethane-acetonitrile-methanol-28% amnmonia water. The flow rate was 1.0 ml/min. The column pressure was maintained at 70 kg/cm2. The spectrophotofluorimeter was set at 300 and 420 nm as excitation and emission wavelengths, respectively. The concentration in each sample was calculated from the appropriate standard calibration curve determined by the least-squares method. The sensitivity of the procedure was 1.0 and 10 pg/ml for plasma and urine, respectively. This procedure gave the concentration of unchanged AM-715 without being affected by metabolites.
Radioisotope (11) and high-pressure liquid chromatography studies (13) have shown that AM-715 undergoes some metabolic alteration but is primarily excreted in unchanged form in both animals and humans. Therefore, a high-pressure liquid chromatography method specific to the unchanged form of AM-715 was used as the assay method in the animal studies. Its sensitivity (detectable limit, 1.0 ,ug/ml), however, was not enough to determine serum concentration of volunteers receiving 200 mg of AM-715; therefore, bioassay was employed in human studies. Human samples were assayed with the cup method, using Escherichia coli NIHJ JC-2 as the test organism (12). The detectable sensitivity limit of this bioassay method for AM-715 was 0.05 ,ug/ml. Metabolites of AM-715 did not affect practically the bioassay of AM-
715.
For inulin determination, the modified Dische method (3) was used. PAH concentrations were determined by the Bratton-Marshall method (4 The five rabbits showed substantial intersubject variation in the concentration of AM-715 in plasma at 30 min after the start of the infusion of AM-715 without probenecid (3.7 to 7.8 ,ug/ml), as compared with the variation found in dogs, as described later. Even so, a relatively uniform excretion ratio of 2.2 to 3.7 was obtained which did not depend on plasma concentrations. This high excretion ratio suggests the tubular secretion of AM-715 in rabbits. Probenecid (30 mg/kg) induced a marked reduction in the excretion Results in dogs. Renal clearance studies were performed with three doses of AM-715 without probenecid and with one dose with probenecid. There were three dogs in each experimental group. None exhibited any significant changes in blood pressure, urine volume, or urinary pH during these experiments. The amount of AM-715 excreted into the urine was almost equal to the amount estimated for glomerular filtration of AM-715 ( Table 2 ). The ratio of renal clearance of AM-715 (22.1 to 25.5 mI/min) to that of inulin (20.1 to 25.0 ml/min) was 1.0 to 1.1 and was not dependent on plasma concentration, which ranged from 4.6 to 13.2 pug/ml. Probenecid (30 mg/kg) had almost no effect on the renal excretion of AM-715. The excretion ratio when probenecid was used was 1.0 ± 0.0 (mean + standard error of three dogs).
The above results suggest that, in dogs, AM-715 is excreted mostly through glomerular filtration. To further examine the contribution of the renal tubules to the excretion of AM-715, a stopflow analysis was conducted. Locations of secretion from the proximal renal tubules and of reabsorption through the distal renal tubules were determined, using PAH, and sodium and potassium, respectively, as markers. Inulin was administered as a marker of glomerular urine.
The ratio of the concentration of creatinine in urine to that in plasma was used as a parameter of concentration in urine. A typical pattern is shown in Fig. 1 was found corresponding to the peak of PAH and the trough of sodium and potassium (Fig. 1) . With the administration of probenecid, the peak of PAH disappeared, but the stop-flow pattern of AM-715 showed no significant change.
To further investigate whether probenecid inhibits the renal excretion of AM-715 or decreases the volume of distribution, serum concentrations were analyzed pharmacokinetically. Table 3 . There were no significant changes in the various parameters, including the volume of distribution of central compartment and the biological half-life, with the administration of probenecid.
Results in humans. Probenecid had no effect on the concentration of AM-715 in serum (Fig.  3) . However, urinary recovery of AM-715 for 12 h after oral administration decreased to about one half with the administration of probenecid (Table 4 ). The mean urinary recovery rate was 28% of the dose without the administration of probenecid and 14% of the dose with the administration of probenecid. Creatinine clearance, AM-715 clearance, and the ratio of AM-715 clearance to creatinine clearance for each time period are shown in Table 4 . The clearance ratios for the period from 3.to 5 h and the period from 5 to 7 h were significantly decreased by the administration of probenecid. When subjects received AM-715 alone, the mean clearance ratios were 2.4 and 3.4, but they declined to near unity with the administration of probenecid.
DISCUSSION
In rabbits, the renal clearance of AM-715 was greater than the glomerular filtration rate (inulin clearance), and the ratio was 2.2 to 3.7. Therefore, it can be said that, in rabbits, AM-715 was excreted through both glomerular filtration and tubular secretion. This evidence is confirmed by the results obtained with the administration of probenecid. Administration of probenecid caused a marked decrease of excretion ratio (Table 1) . Probenecid is known to be actively secreted by the renal tubules and to block the active secretion of many organic acids by its potent affinity for the carrier for anion transport (2) . Renal tubular secretion of pipemidic acid, a dipolar ionic quinolone derivative similar to AM-715, is also competitively inhibited by probenecid in dogs (10) . The reduction of the excretion ratio of AM-715 in rabbits with the administration of probenecid could also be due to the same mechanism, owing to the structural similarities of these compounds. The excretion ratio clearance and was reduced remarkably with the administration of probenecid. Statistical analysis showed that there were significant differences between the ratios of AM-715 renal clearance to creatinine clearance obtained with the administration of probenecid and the ratios obtained without probenecid for the clearance periods of 3 to 5 and 5 to 7 h. The clearance ratios decreased to near unity with the administration of probenecid. From this evidence, it appears that renal tubular secretion is involved in the urinary excretion of AM-715 in humans in addition to glomerular filtration. Pharmacokinetic parameters such as peak concentration and biological half-life were not changed with the administration of probenecid as expected, owing to the large intersubject variation in serum level.
The results of the present study suggest that the renal excretion of AM-715 takes place mostly through glomerular filtration in dogs. In rabbits and humans, however, renal tubular secretion is also involved, in addition to glomerular filtration. These results suggest that the renal excretion of AM-715 differs with animal species.
